Marker Localization Patent Granted to Cianna Medical
Summary
USPTO granted Patent US12588829B2 to Cianna Medical, Inc. for apparatus, systems, and methods used to localize markers or tissue structures within a patient's body, such as for breast lesion localization. The patent (18 claims) covers implantable markers and electromagnetic signal probes for detecting and removing tissue specimens including lesions.
What changed
USPTO granted Patent US12588829B2 to Cianna Medical, Inc. covering apparatus, systems, and methods for localizing markers or tissue structures within a patient's body, particularly for procedures like breast lesion removal. The technology includes implantable markers deployed within target tissue regions and a probe that transmits and receives electromagnetic signals to detect and localize the markers, enabling precise surgical removal of tissue specimens including the marker and lesion.
Patent holders should ensure proper maintenance fees are paid to preserve patent rights. Healthcare providers and medical device manufacturers should review the claims to assess potential infringement exposure for similar marker localization technologies. No immediate compliance actions are required for this patent grant.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Apparatus, systems, and methods for localizing markers or tissue structures within a body
Grant US12588829B2 Kind: B2 Mar 31, 2026
Assignee
Cianna Medical, Inc.
Inventors
Eduardo Chi Sing, Mark A. Cole, Tommy G. Nguyen
Abstract
Apparatus, systems, and methods are provided for localizing lesions within a patient's body, e.g., within a breast. The system may include one or more markers implantable within or around the target tissue region, and a probe for transmitting and receiving electromagnetic signals to detect the one or more markers. During use, the marker(s) are into a target tissue region, and the probe is placed against the patient's skin to detect and localize the marker(s). A tissue specimen, including the lesion and the marker(s), is then removed from the target tissue region based at least in part on the localization information from the probe.
CPC Classifications
A61B 5/061 A61B 5/0507 A61B 5/06 A61B 90/39 A61B 5/064 A61B 90/37 A61B 2017/00438 A61B 2017/00442 A61B 2034/2051 A61B 2034/2072 A61B 2090/3908 A61B 2090/397 A61B 2090/3975 A61B 2090/3987
Filing Date
2024-03-15
Application No.
18606263
Claims
18
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.